Exicure (XCUR)

• Market cap: $38.5M
• 1 day: -2.79%
• 5 days: -9.76%
• 1 month: -24.59%
• 3 months: -40.80%
• 6 months: -23.12%
• Year to date: -61.00%
• 1 year: 211.58%
• 5 years: -98.11%
• 10 years: -98.50%
• Sector: Healthcare
• Industry: Biotechnology

About: Exicure Inc is an early-stage biotechnology company focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets. It operates in a single segment which is Biotechnology.

Employees: 8

Fund manager confidence

Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)

33% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 3

17% more funds holding

Funds holding: 12 [Q1] → 14 (+2) [Q2]

0.76% more ownership

Funds ownership: 5.1% [Q1] → 5.86% (+0.76%) [Q2]

38% less capital invested

Capital invested by funds: $4.12M [Q1] → $2.55M (-$1.57M) [Q2]